Climb Bio Inc.

XNAS:CLYM   4:00:00 PM EDT
16.40
-0.88 (-5.09%)
7:30:04 PM EDT: $16.64 +0.24 (+1.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Climb Bio Inc. Stock, XNAS:CLYM

20 William Street, Suite 145, Wellesley Hills, Massachusetts 02481-4103
United States of America
Phone: +1.866.857.2596
Number of Employees: 9
http://www.climbbio.com

Description

Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 antibody designed for a broad range of B-cell mediated diseases. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wellesley Hills, MA.